These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30157717)

  • 1. Relationship between serum vascular cell adhesion molecule-1 and endothelin-1 levels with organ involvement and disease activity in systemic lupus erythematosus patients.
    Hajialilo M; Tayari P; Ghorbanihaghjo A; Khabbazi A; Malek Mahdavi A; Rashtchizadeh N
    Lupus; 2018 Oct; 27(12):1918-1925. PubMed ID: 30157717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical significance of selected endothelial activation markers in patients with systemic lupus erythematosus.
    Kuryliszyn-Moskal A; Klimiuk PA; Ciolkiewicz M; Sierakowski S
    J Rheumatol; 2008 Jul; 35(7):1307-13. PubMed ID: 18484695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells, endothelial apoptosis and soluble markers of endothelial dysfunction in patients with systemic lupus erythematosus-related vasculitis.
    Kluz J; Kopeć W; Jakobsche-Policht U; Adamiec R
    Int Angiol; 2009 Jun; 28(3):192-201. PubMed ID: 19506538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of nailfold capillaroscopy in systemic lupus erythematosus: correlation with endothelial cell activation markers and disease activity.
    Kuryliszyn-Moskal A; Ciolkiewicz M; Klimiuk PA; Sierakowski S
    Scand J Rheumatol; 2009; 38(1):38-45. PubMed ID: 18991188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pentraxin 3 as a biomarker of local inflammatory response to vascular injury in systemic lupus erythematosus.
    Cieślik P; Hrycek A
    Autoimmunity; 2015 Jun; 48(4):242-50. PubMed ID: 25401491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased soluble vascular cell adhesion molecule 1 concentrations in patients with primary or systemic lupus erythematosus-related antiphospholipid syndrome: correlations with the severity of thrombosis.
    Kaplanski G; Cacoub P; Farnarier C; Marin V; Grégoire R; Gatel A; Durand JM; Harlé JR; Bongrand P; Piette JC
    Arthritis Rheum; 2000 Jan; 43(1):55-64. PubMed ID: 10643700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch-Schönlein purpura and pediatric systemic lupus erythematosus.
    Gattorno M; Vignola S; Barbano G; Sormani MP; Sabatini F; Buoncompagni A; Picco P; Pistoia V
    J Rheumatol; 2000 Sep; 27(9):2251-5. PubMed ID: 10990243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subclinical disease activity in systemic lupus erythematosus: immunoinflammatory markers do not normalize in clinical remission.
    Wais T; Fierz W; Stoll T; Villiger PM
    J Rheumatol; 2003 Oct; 30(10):2133-9. PubMed ID: 14528506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial function and markers of endothelial activation in relation to cardiovascular disease in systemic lupus erythematosus.
    Svenungsson E; Cederholm A; Jensen-Urstad K; Fei GZ; de Faire U; Frostegård J
    Scand J Rheumatol; 2008; 37(5):352-9. PubMed ID: 18666029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble vascular cell adhesion molecule-1 indicates SLE disease activity and specific organ involvement.
    Pizarro S; Monárrez Espino J; Ruiz A; Jara LJ; Nava A; Riebeling-Navarro C
    Rev Alerg Mex; 2007; 54(6):189-95. PubMed ID: 18693542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased serum leptin levels are associated with metabolic syndrome and carotid intima media thickness in premenopausal systemic lupus erythematosus patients without clinical atherosclerotic vascular events.
    Demir S; Erten G; Artım-Esen B; Şahinkaya Y; Pehlivan Ö; Alpay-Kanıtez N; Deniz G; Inanç M
    Lupus; 2018 Aug; 27(9):1509-1516. PubMed ID: 29954279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble urokinase plasminogen activator receptor levels reflect organ damage in systemic lupus erythematosus.
    Enocsson H; Wetterö J; Skogh T; Sjöwall C
    Transl Res; 2013 Nov; 162(5):287-96. PubMed ID: 23916811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated plasma concentrations of nitric oxide, soluble thrombomodulin and soluble vascular cell adhesion molecule-1 in patients with systemic lupus erythematosus.
    Ho CY; Wong CK; Li EK; Tam LS; Lam CW
    Rheumatology (Oxford); 2003 Jan; 42(1):117-22. PubMed ID: 12509624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced ADAMTS13 activity is associated with thrombotic risk in systemic lupus erythematosus.
    Martin-Rodriguez S; Reverter JC; Tàssies D; Espinosa G; Heras M; Pino M; Escolar G; Diaz-Ricart M
    Lupus; 2015 Oct; 24(11):1143-9. PubMed ID: 25824235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved monitoring of clinical response in Systemic Lupus Erythematosus by longitudinal trend in soluble vascular cell adhesion molecule-1.
    Lewis MJ; Vyse S; Shields AM; Zou L; Khamashta M; Gordon PA; Pitzalis C; Vyse TJ; D'Cruz DP
    Arthritis Res Ther; 2016 Jan; 18():5. PubMed ID: 26746423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated soluble intercellular adhesion molecule-1 levels in patients with systemic lupus erythematosus: relation to insulin resistance.
    Tso TK; Huang WN
    J Rheumatol; 2007 Apr; 34(4):726-30. PubMed ID: 17309130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thrombomodulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity.
    Boehme MW; Raeth U; Galle PR; Stremmel W; Scherbaum WA
    Clin Exp Immunol; 2000 Jan; 119(1):189-95. PubMed ID: 10606982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus.
    Robak E; Kierstan M; Cebula B; Krawczynska A; Sysa-Jedrzejowska A; Wierzbowska A; Smolewski P; Robak T
    Lupus; 2009 Apr; 18(4):332-41. PubMed ID: 19276301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-associated antigens in systemic sclerosis and systemic lupus erythematosus: associations with organ manifestations, immunolaboratory markers and disease activity indices.
    Szekanecz E; Szucs G; Szekanecz Z; Tarr T; Antal-Szalmás P; Szamosi S; Szántó J; Kiss E
    J Autoimmun; 2008 Dec; 31(4):372-6. PubMed ID: 18926664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble adhesion molecules (sVCAM-1, sE-selectin), vascular endothelial growth factor (VEGF) and endothelin-1 in patients with systemic sclerosis: relationship to organ systemic involvement.
    Kuryliszyn-Moskal A; Klimiuk PA; Sierakowski S
    Clin Rheumatol; 2005 Apr; 24(2):111-6. PubMed ID: 15349798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.